...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Upcoming FUNDING opportunity -- Post-Covid New-Onset of Diabetes


https://grants.nih.gov/grants/guide/notice-files/NOT-DK-22-018.html

 

Notice of Intent to Publish a Funding Opportunity Announcement for Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)
Notice Number:
NOT-DK-22-018

Key Dates

Release Date:
March 23, 2022
Estimated Publication Date of Funding Opportunity Announcement:
July 01, 2022
First Estimated Application Due Date:
December 20, 2022
Earliest Estimated Award Date:
July 01, 2023
Earliest Estimated Start Date:
July 01, 2023
Related Announcements

None

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications to establish a longitudinal cohort of individuals who developed diabetes following SARS-CoV-2 infection for the purpose of characterizing individuals who develop diabetes post-infection and understanding their clinical course.

This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. 

The FOA is expected to be published in late spring 2022 with an expected application due date in late fall 2022.

 

Anticipated Eligible Organizations
Public/State Controlled Institution of Higher Education
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Regional Organization
Eligible Agencies of the Federal Government

Applications are not being solicited at this time.  

Inquiries
 

Please direct all inquiries to:

Barbara Linder, M.D., Ph.D.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

(301) 594-0021

Maren Laughlin, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phone: (301) 594-8802
E-mail: [email protected]

 

Share
New Message
Please login to post a reply